ArticleCurrent pharmaceutical design2011

Development of novel therapeutics targeting the urokinase plasminogen activator receptor (uPAR) and their translation toward the clinic.

Andrew P Mazar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.